P24071 (FCAR_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Immunoglobulin alpha Fc receptor Short name=IgA Fc receptor Alternative name(s): CD_antigen=CD89 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 287 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds to the Fc region of immunoglobulins alpha. Mediates several functions including cytokine production. |
| Subunit structure | Associates with the Fc epsilon RI gamma 2 receptor inducing tyrosine phosphorylation of gamma 2. Ref.10 |
| Subcellular location | Isoform A.1: Cell membrane; Single-pass type I membrane protein. Isoform A.2: Cell membrane; Single-pass type I membrane protein. Isoform A.3: Cell membrane; Single-pass type I membrane protein. Isoform B-delta-S2: Secreted. |
| Tissue specificity | Isoform A.1, isoform A.2 and isoform A.3 are differentially expressed between blood and mucosal myeloid cells. Isoform A.1, isoform A.2 and isoform A.3 are expressed in monocytes. Isoform A.1 and isoform A.2 are expressed in alveolar macrophages; however only one isoform is expressed at alveolar macrophages surfaces. Ref.3 Ref.5 |
| Sequence similarities | Contains 2 Ig-like C2-type (immunoglobulin-like) domains. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane Secreted |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Immunoglobulin domain Repeat Signal Transmembrane Transmembrane helix |
| Ligand | IgA-binding protein |
| Molecular function | Receptor |
| PTM | Disulfide bond Glycoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | immune response Traceable author statement PubMed 10835685. Source: ProtInc |
| Cellular_component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell integral to plasma membraneTraceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 11 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform A.1 (identifier: P24071-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform A.2 (identifier: P24071-2) The sequence of this isoform differs from the canonical sequence as follows: 195-216: Missing. | ||||||
| Isoform A.3 (identifier: P24071-3) Also known as: RLA2; The sequence of this isoform differs from the canonical sequence as follows: 121-216: Missing. | ||||||
| Isoform B (identifier: P24071-4) The sequence of this isoform differs from the canonical sequence as follows: 217-287: DSIHQDYTTQ...TFARTPSVCK → GRYRPVQPCVWVGCPGPCHRAGI | ||||||
| Isoform B-delta-S2 (identifier: P24071-5) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. 217-287: DSIHQDYTTQ...TFARTPSVCK → GRYRPVQPCVWVGCPGPCHRAGI | ||||||
| Note: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. | ||||||
| Isoform U02 (identifier: P24071-6) The sequence of this isoform differs from the canonical sequence as follows: 24-24: G → GRYISEHFWCRSLGCNPVNDASAQRPG 195-216: Missing. | ||||||
| Isoform L10 (identifier: P24071-7) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. 24-120: Missing. | ||||||
| Isoform U09 (identifier: P24071-8) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. 193-287: CYGWYNRSPY...TFARTPSVCK → LHPPRLHDAELDPHGRGRTGPRGSLGHTG | ||||||
| Isoform U10 (identifier: P24071-9) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. 115-210: Missing. | ||||||
| Isoform U11 (identifier: P24071-10) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. | ||||||
| Isoform U13 (identifier: P24071-11) The sequence of this isoform differs from the canonical sequence as follows: 12-23: Missing. 195-216: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 22 – 287 | 266 | Immunoglobulin alpha Fc receptor | PRO_0000015138 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 22 – 227 | 206 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 228 – 246 | 19 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 247 – 287 | 41 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 42 – 107 | 66 | Ig-like C2-type 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 139 – 200 | 62 | Ig-like C2-type 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 65 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 79 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 141 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 177 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 186 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 198 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 49 ↔ 100 | Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 146 ↔ 193 | Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 12 – 23 | 12 | Missing in isoform B-delta-S2, isoform L10, isoform U09, isoform U10, isoform U11 and isoform U13. | VSP_002632 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 24 – 120 | 97 | Missing in isoform L10. | VSP_043565 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 24 | 1 | G → GRYISEHFWCRSLGCNPVND ASAQRPG in isoform U02. | VSP_002633 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 115 – 210 | 96 | Missing in isoform U10. | VSP_043566 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 121 – 216 | 96 | Missing in isoform A.3. | VSP_002634 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 193 – 287 | 95 | CYGWY…PSVCK → LHPPRLHDAELDPHGRGRTG PRGSLGHTG in isoform U09. | VSP_043567 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 195 – 216 | 22 | Missing in isoform A.2, isoform U02 and isoform U13. | VSP_002635 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 217 – 287 | 71 | DSIHQ…PSVCK → GRYRPVQPCVWVGCPGPCHR AGI in isoform B and isoform B-delta-S2. | VSP_002636 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 113 | 1 | D → N. Ref.7 Corresponds to variant rs11666735 [ dbSNP | Ensembl ]. | VAR_049996 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 269 | 1 | S → G. Ref.7 Corresponds to variant rs16986050 [ dbSNP | Ensembl ]. | VAR_049997 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 23 – 25 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 31 – 35 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 37 – 40 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 45 – 49 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 64 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 67 – 70 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 72 – 74 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 77 – 79 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 84 – 87 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 92 – 94 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 96 – 104 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 105 – 107 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 108 – 111 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 115 – 120 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 127 – 132 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 134 – 136 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 143 – 147 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 149 – 151 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 154 – 160 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 168 – 171 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 173 – 179 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 185 – 187 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 189 – 196 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 198 – 200 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 211 – 215 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression cloning of a human Fc receptor for IgA." Maliszewski C.R., March C.J., Schoenborn M.A., Gimpel S., Shen L. J. Exp. Med. 172:1665-1672(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A.1). |
| [2] | "Structure of the gene for the human myeloid IgA Fc receptor (CD89)." de Wit T.P.M., Morton H.C., Capel P.J.A., van de Winkel J.G.J. J. Immunol. 155:1203-1209(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A.1). Tissue: Bone marrow. |
| [3] | "Identification of Fc alpha receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages." Patry C., Sibille Y., Lehuen A., Monteiro R.C. J. Immunol. 156:4442-4448(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A.2 AND A.3), TISSUE SPECIFICITY. Tissue: Alveolar macrophage and Monocyte. |
| [4] | van Dijk T.B., Morton H.C., Caldenhoven E., Bracke M., Raaijmakers J.A.M., Lammers J.W.J., Koenderman L., Groot R.P. Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE (ISOFORMS B AND B-DELTA-S2). |
| [5] | "Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils." Pleass R.J., Andrews P.D., Kerr M.A., Woof J.M. Biochem. J. 318:771-777(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A.3), TISSUE SPECIFICITY. |
| [6] | "IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells." Toyabe S., Kuwano Y., Takeda K., Uchiyama M., Abo T. Clin. Exp. Immunol. 110:226-232(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A.2; A.3; L10; U02; U09; U10; U11 AND U13). |
| [7] | "Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins." Abi-Rached L., Dorighi K., Norman P.J., Yawata M., Parham P. J. Immunol. 178:7943-7954(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A.1), VARIANTS ASN-113 AND GLY-269. |
| [8] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A.1). Tissue: Blood. |
| [10] | "Association of IgA-Fc receptors (Fc alpha R) with Fc epsilon RI gamma 2 subunits in U937 cells. Aggregation induces the tyrosine phosphorylation of gamma 2." Pfefferkorn L.C., Yeaman G.R. J. Immunol. 153:3228-3236(1994) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT. |
| [11] | "An unappreciated role for RNA surveillance." Hillman R.T., Green R.E., Brenner S.E. Genome Biol. 5:R8.1-R8.16(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S). |
| [12] | "Crystal structure of the ectodomain of human FcalphaRI." Ding Y., Xu G., Yang M., Yao M., Gao G.F., Wang L., Zhang W., Rao Z. J. Biol. Chem. 278:27966-27970(2003) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 21-229, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Entry information
| Entry name | FCAR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P24071 Secondary accession number(s): Q13603 Q9UEK0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
